Company data
Aktis Oncology, Inc. employees and revenue per employee
AKTS · Biotechnology · $969M market cap
Aktis Oncology, Inc. had 200,000 employees at the end of fiscal Dec 2025. Revenue for the year was $6.5M, or $32 per employee.
Employees
200,000
Revenue
$6.5M
Revenue / employee
$32
Peer median $459K
Rank in industry
108 of 108
Biotechnology
Headcount against revenue
Both lines start at 100 in the first year we hold, so you can see which one grew faster.
Only one fiscal year on file so far, so there is no trend to draw yet.
Aktis Oncology, Inc. against similar companies
The closest industry peers by revenue, from Biotechnology.
| Company | Employees | Revenue | Revenue / employee | Shape |
|---|---|---|---|---|
| CBIO Crescent Biopharma, Inc. | 44 | $10.8M | $246K | — |
| JANX Janux Therapeutics, Inc. | 109 | $10.0M | $92K | Hiring into decline |
| PRAX Praxis Precision Medicines, Inc. | 116 | $8.6M | $74K | Efficient growth |
| PGEN Precigen, Inc. | 160 | $9.7M | $61K | Efficient growth |
| ZBIO Zenas BioPharma, Inc. | 167 | $10.0M | $60K | Efficient growth |
| IMNM Immunome, Inc. | 177 | $6.9M | $39K | Hiring into decline |
| CGON CG Oncology Inc. | 142 | $4.0M | $28K | Efficient growth |
| CRNX Crinetics Pharmaceuticals, Inc. | 594 | $7.7M | $13K | Efficient growth |
| AKTS Aktis Oncology, Inc. | 200,000 | $6.5M | $32 | — |
Questions about Aktis Oncology, Inc.
- How many employees does Aktis Oncology, Inc. have?
- Aktis Oncology, Inc. reported 200,000 employees for the fiscal year ending Dec 2025, in the annual report it filed on March 30, 2026.
- What is Aktis Oncology, Inc.'s revenue per employee?
- Aktis Oncology, Inc. brought in $6.5M of revenue in fiscal Dec 2025, which is $32 per employee. That ranks 108 of 108 companies we track in Biotechnology, where the median is $459K.
- Where do these numbers come from?
- Employee counts and revenue are taken from each company's own annual report (Form 10-K). Open roles are counted from the company's public job board where we have matched one. Companies report headcount once a year, sometimes rounded, so small changes can be noise.
Free game
Think you can pick better than the S&P 500?
Pick 15 stocks, lock them in, and we score them against the index every trading day for ten years. Free, with a public leaderboard.
Enter the challengeMore data
Compare AKTS with the rest of the market
See who earns the most per employee, who is hiring, and who is cutting, across every company we track.
Source: employee counts and revenue as stated in Aktis Oncology, Inc.'s annual reports (Form 10-K), latest filed March 30, 2026. This is data, not a recommendation to buy or sell AKTS.